Search Results
You are looking at 1 - 3 of 3 items for
- Author: C Guzman x
- Refine by access: All content x
Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, 76230 Querétaro, México
Search for other papers by C Zermeño in
Google Scholar
PubMed
Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, 76230 Querétaro, México
Search for other papers by J Guzmán-Morales in
Google Scholar
PubMed
Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, 76230 Querétaro, México
Search for other papers by Y Macotela in
Google Scholar
PubMed
Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, 76230 Querétaro, México
Search for other papers by G Nava in
Google Scholar
PubMed
Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, 76230 Querétaro, México
Search for other papers by F López-Barrera in
Google Scholar
PubMed
Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, 76230 Querétaro, México
Search for other papers by J B Kouri in
Google Scholar
PubMed
Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, 76230 Querétaro, México
Search for other papers by C Lavalle in
Google Scholar
PubMed
Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, 76230 Querétaro, México
Search for other papers by G Martínez de la Escalera in
Google Scholar
PubMed
Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, 76230 Querétaro, México
Search for other papers by C Clapp in
Google Scholar
PubMed
The apoptosis of chondrocytes plays an important role in endochondral bone formation and in cartilage degradation during aging and disease. Prolactin (PRL) is produced in chondrocytes and is known to promote the survival of various cell types. Here we show that articular chondrocytes from rat postpubescent and adult cartilage express the long form of the PRL receptor as revealed by immunohistochemistry of cartilage sections and by RT-PCR and Western blot analyses of the isolated chondrocytes. Furthermore, we demonstrate that PRL inhibits the apoptosis of these same chondrocytes cultured in low-serum. Chondrocyte apoptosis was measured by hypodiploid DNA content determined by flow cytometry and by DNA fragmentation evaluated by the ELISA and the TUNEL methods. The anti-apoptotic effect of PRL was dose-dependent and was prevented by heat inactivation. These data demonstrate that PRL can act as a survival factor for chondrocytes and that it has potential preventive and therapeutic value in arthropathies characterized by cartilage degradation.
Search for other papers by RA Medina in
Google Scholar
PubMed
Search for other papers by AM Meneses in
Google Scholar
PubMed
Search for other papers by JC Vera in
Google Scholar
PubMed
Search for other papers by C Guzman in
Google Scholar
PubMed
Search for other papers by F Nualart in
Google Scholar
PubMed
Search for other papers by F Rodriguez in
Google Scholar
PubMed
Search for other papers by M de los Angeles Garcia in
Google Scholar
PubMed
Search for other papers by S Kato in
Google Scholar
PubMed
Search for other papers by N Espinoza in
Google Scholar
PubMed
Search for other papers by C Monso in
Google Scholar
PubMed
Search for other papers by A Carvajal in
Google Scholar
PubMed
Search for other papers by M Pinto in
Google Scholar
PubMed
Search for other papers by GI Owen in
Google Scholar
PubMed
Estrogen replacement therapy and other unopposed estrogen treatments increase the incidence of endometrial abnormalities, including cancer. However, this effect is counteracted by the co-administration of progesterone. In the endometrium, glucose transporter (GLUT) expression and glucose transport are known to fluctuate throughout the menstrual cycle. Here, we determined the effect of estrogen and progesterone on the expression of GLUT1-4 and on the transport of deoxyglucose in Ishikawa endometrial cancer cells. Cells were incubated with estrogen, progesterone or combined estrogen and progesterone for 24 h and the effect on the expression of GLUT1-4 and on deoxyglucose transport was determined. We show that GLUT1 expression is upregulated by estrogen and progesterone individually, but that combined estrogen and progesterone treatment reverses this increase. Hormonal treatments do not affect GLUT2, GLUT3 or GLUT4 expression. Transport studies demonstrate that estrogen increases deoxyglucose transport at Michaelis-Menten constants (Kms) corresponding to GLUT1/4, an effect which disappears when progesterone is added concomitantly. These data demonstrate that different hormonal treatments differentially regulate GLUT expression and glucose transport in this endometrial cancer cell line. This regulation mirrors the role played by estrogen and progesterone on the incidence of cancer in this tissue and suggests that GLUT1 may be utilized by endometrial cancer cells to fuel their demand for increased energy requirement.
Search for other papers by Andre Sarmento-Cabral in
Google Scholar
PubMed
Search for other papers by Mercedes del Rio-Moreno in
Google Scholar
PubMed
Search for other papers by Mari C Vazquez-Borrego in
Google Scholar
PubMed
Search for other papers by Mariyah Mahmood in
Google Scholar
PubMed
Search for other papers by Elena Gutierrez-Casado in
Google Scholar
PubMed
Search for other papers by Natalie Pelke in
Google Scholar
PubMed
Search for other papers by Grace Guzman in
Google Scholar
PubMed
Search for other papers by Papasani V Subbaiah in
Google Scholar
PubMed
Search for other papers by Jose Cordoba-Chacon in
Google Scholar
PubMed
Search for other papers by Shoshana Yakar in
Google Scholar
PubMed
Search for other papers by Rhonda D Kineman in
Google Scholar
PubMed
A reduction in hepatocyte growth hormone (GH)-signaling promotes non-alcoholic fatty liver disease (NAFLD). However, debate remains as to the relative contribution of the direct effects of GH on hepatocyte function vs indirect effects, via alterations in insulin-like growth factor 1 (IGF1). To isolate the role of hepatocyte GH receptor (GHR) signaling, independent of changes in IGF1, mice with adult-onset, hepatocyte-specific GHR knockdown (aHepGHRkd) were treated with a vector expressing rat IGF1 targeted specifically to hepatocytes. Compared to GHR-intact mice, aHepGHRkd reduced circulating IGF1 and elevated GH. In male aHepGHRkd, the shift in IGF1/GH did not alter plasma glucose or non-esterified fatty acids (NEFA), but was associated with increased insulin, enhanced systemic lipid oxidation and reduced white adipose tissue (WAT) mass. Livers of male aHepGHRkd exhibited steatosis associated with increased de novo lipogenesis, hepatocyte ballooning and inflammation. In female aHepGHRkd, hepatic GHR protein levels were not detectable, but moderate levels of IGF1 were maintained, with minimal alterations in systemic metabolism and no evidence of steatosis. Reconstitution of hepatocyte IGF1 in male aHepGHRkd lowered GH and normalized insulin, whole body lipid utilization and WAT mass. However, IGF1 reconstitution did not reduce steatosis or eliminate liver injury. RNAseq analysis showed IGF1 reconstitution did not impact aHepGHRkd-induced changes in liver gene expression, despite changes in systemic metabolism. These results demonstrate the impact of aHepGHRkd is sexually dimorphic and the steatosis and liver injury observed in male aHepGHRkd mice is autonomous of IGF1, suggesting GH acts directly on the adult hepatocyte to control NAFLD progression.
